Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04180644 · ClinicalTrials.gov registry record

Skin Tape Transcriptome Methods in Children

A clinical trial of Atopic Dermatitis, sponsored by National Jewish Health.

Completed
Registry status
20
Enrollment target
1
Study location

NCT04180644 is a study of Atopic Dermatitis that has completed, run by National Jewish Health. The registered enrollment target is 20 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04180644, a study of Atopic Dermatitis, has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

This pilot study will evaluate new methods for the collection, storage, shipment, and RNA extraction of skin tape specimens from children with atopic dermatitis (AD) that will facilitate the multi-center SunBeam Birth Cohort study. Additionally, this pilot study will test new methods for the generation of whole transcriptome sequencing data from skin tape RNA and whether these data reflect the transcriptional state of the skin in health and disease.

Conditions Studied

Interventions

  • OTHER Skin tape strips

Study Locations (1)

Colorado

  • National Jewish Health and University of Colorado Denver - Denver

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-01-10
Est. Completion 2020-02-05

Sponsor

National Jewish Health

83 total trials

What the Registry Record Tells You About NCT04180644

The ClinicalTrials.gov registry entry for NCT04180644 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which Skin tape strips is the first listed.

NCT04180644 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04180644 about?

NCT04180644 is a clinical study titled "Skin Tape Transcriptome Methods in Children". This pilot study will evaluate new methods for the collection, storage, shipment, and RNA extraction of skin tape specimens from children with atopic dermatitis (AD) that will facilitate the multi-center SunBeam Birth Cohort study. Additionally, this pilot study will test new methods for the generat...

What is the current status of trial NCT04180644?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2020-01-10. Estimated completion is 2020-02-05.

What conditions does trial NCT04180644 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT04180644?

The interventions under investigation include: Skin tape strips (OTHER).

Who is sponsoring clinical trial NCT04180644?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04180644 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.